CIK 0001326110 · Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 431979754
- Phone
- (844) 696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,119,848
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,119,848. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-31 | Adcock Richard CEO & President | Option exercise · Restricted Stock Units | −34,483 | 120,697 | ||
| 2023-12-29 | SOON-SHIONG PATRICK See remarks | Other acquisition · Amended and Restated Promissory Note | +0 | $380,000,000.00 | $0 | |
| 2023-12-29 | SOON-SHIONG PATRICK See remarks | Other acquisition · Convertible Promissory Note | +0 | $30,000,000.00 | $0 | |
| 2023-12-15 | LAUER REGAN J Chief Accounting Officer | Option exercise | +21,030 | 74,932 | ||
| 2023-12-15 | LAUER REGAN J Chief Accounting Officer | Option exercise · Restricted Stock Units | −21,030 | 21,031 | ||
| 2023-09-11 | SOON-SHIONG PATRICK See remarks | Other acquisition | +129,127,017 | $1.29 | $166.6M | 129,227,017 |
| 2023-09-11 | SOON-SHIONG PATRICK See remarks | Other acquisition | +47,557,934 | $1.29 | $61.3M | 47,557,934 |
| 2023-09-11 | SOON-SHIONG PATRICK See remarks | Other acquisition | +32,606,985 | $1.29 | $42.1M | 32,606,985 |
| 2023-09-11 | SOON-SHIONG PATRICK See remarks | Other disposition · Amended and Restated Convertible Promissory Note | −0 | |||
| 2023-09-11 | SOON-SHIONG PATRICK See remarks | Other disposition · Amended and Restated Convertible Promissory Note | −0 | |||
| 2023-09-11 | SOON-SHIONG PATRICK See remarks | Other disposition · Second Amended and Restated Convertible Promissory Note | −0 | |||
| 2023-09-11 | SOON-SHIONG PATRICK See remarks | Other disposition · Second Amended and Restated Convertible Promissory Note | −0 | |||
| 2023-09-11 | SOON-SHIONG PATRICK See remarks | Other disposition · Second Amended and Restated Convertible Promissory Note | −0 | |||
| 2023-09-11 | SOON-SHIONG PATRICK See remarks | Purchase · Convertible Promissory Note | +0 | $200,000,000.00 | $0 | |
| 2023-09-01 | Sachs David C. Chief Financial Officer | Option exercise | +70,744 | 122,042 | ||
| 2023-09-01 | Sachs David C. Chief Financial Officer | Option exercise · Restricted Stock Units | −70,744 | 70,745 | ||
| 2023-09-01 | LAUER REGAN J Chief Accounting Officer | Option exercise | +32,872 | 53,902 | ||
| 2023-09-01 | LAUER REGAN J Chief Accounting Officer | Option exercise · Restricted Stock Units | −32,872 | 32,872 | ||
| 2023-09-01 | Simon Barry J. Director | Option exercise | +57,199 | 3,088,655 | ||
| 2023-09-01 | Simon Barry J. Director | Option exercise · Restricted Stock Units | −57,199 | 57,200 |
Page 9 of 12 · 226 trades